Chrysafis
Andreou
*abc,
Konstantinos
Plakas
d,
Naxhije
Berisha
ae,
Mathieu
Gigoux
f,
Lauren E.
Rosch
d,
Rustin
Mirsafavi
a,
Anton
Oseledchyk
a,
Suchetan
Pal
a,
Dmitriy
Zamarin
f,
Taha
Merghoub
f,
Michael R.
Detty
d and
Moritz F.
Kircher
gh
aDepartment of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USA
bCenter for Molecular Imaging and Nanotechnology (CMINT), Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
cDepartment of Electrical and Computer Engineering, University of Cyprus, Nicosia, 1678 Nicosia, Cyprus. E-mail: andreou.chrysafis@ucy.ac.cy
dDepartment of Chemistry, University at Buffalo, The State University of New York, Buffalo, New York 14260-3000, USA
eDepartment of Chemistry, The Graduate Center of the City University of New York, New York, NY 10016, USA
fDepartment of Immunology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USA
gDepartment of Imaging, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA
hDepartment of Radiology, Brigham & Women’s Hospital and Harvard Medical School, Boston, MA 02215, USA
First published on 29th June 2023
Correction for ‘Multiplexed molecular imaging with surface enhanced resonance Raman scattering nanoprobes reveals immunotherapy response in mice via multichannel image segmentation’ by Chrysafis Andreou et al., Nanoscale Horiz., 2022, 7, 1540–1552, https://doi.org/10.1039/d2nh00331g.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
This journal is © The Royal Society of Chemistry 2023 |